mitralballongvalvotomi

Mitralballongvalvotomi, also known as percutaneous mitral balloon valvuloplasty, is a minimally invasive procedure used to treat mitral stenosis, a condition where the mitral valve in the heart becomes narrowed. This narrowing restricts blood flow from the left atrium to the left ventricle.

The procedure involves inserting a thin, flexible tube called a catheter through a vein, typically in the groin, and guiding it to the heart. Once the catheter reaches the mitral valve, a small balloon at the tip is inflated. This inflation widens the narrowed valve leaflets, improving blood flow. The balloon is then deflated, and the catheter is removed.

Mitralballongvalvotomi is generally considered a safe and effective treatment for carefully selected patients with significant mitral stenosis, especially those who are not good candidates for open-heart surgery. The success of the procedure depends on the condition of the valve leaflets; it is most effective when the leaflets are flexible and not severely calcified.

Potential risks, though uncommon, include damage to the valve, blood clots, stroke, and bleeding at the catheter insertion site. Recovery is typically faster than with surgical valve replacement, with most patients able to return to normal activities within a few days to weeks. Regular follow-up with a cardiologist is necessary to monitor the valve function and overall heart health.